175 related articles for article (PubMed ID: 34449940)
1. Structure-Based Design, Synthesis, and Biological Evaluation of Hsp90β-Selective Inhibitors.
Chaudhury S; Narasimharao Meka P; Banerjee M; Kent CN; Blagg BSJ
Chemistry; 2021 Oct; 27(59):14747-14764. PubMed ID: 34449940
[TBL] [Abstract][Full Text] [Related]
2. Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor.
Khandelwal A; Kent CN; Balch M; Peng S; Mishra SJ; Deng J; Day VW; Liu W; Subramanian C; Cohen M; Holzbeierlein JM; Matts R; Blagg BSJ
Nat Commun; 2018 Jan; 9(1):425. PubMed ID: 29382832
[TBL] [Abstract][Full Text] [Related]
3. The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with
Mishra SJ; Liu W; Beebe K; Banerjee M; Kent CN; Munthali V; Koren J; Taylor JA; Neckers LM; Holzbeierlein J; Blagg BSJ
J Med Chem; 2021 Feb; 64(3):1545-1557. PubMed ID: 33428418
[TBL] [Abstract][Full Text] [Related]
4. The hERG channel is dependent upon the Hsp90α isoform for maturation and trafficking.
Peterson LB; Eskew JD; Vielhauer GA; Blagg BS
Mol Pharm; 2012 Jun; 9(6):1841-6. PubMed ID: 22554505
[TBL] [Abstract][Full Text] [Related]
5. Selective Inhibition of the Hsp90α Isoform.
Mishra SJ; Khandelwal A; Banerjee M; Balch M; Peng S; Davis RE; Merfeld T; Munthali V; Deng J; Matts RL; Blagg BSJ
Angew Chem Int Ed Engl; 2021 May; 60(19):10547-10551. PubMed ID: 33621416
[TBL] [Abstract][Full Text] [Related]
6. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants.
Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L
PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842
[TBL] [Abstract][Full Text] [Related]
7. Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90).
Mak OW; Chand R; Reynisson J; Leung IKH
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717777
[TBL] [Abstract][Full Text] [Related]
8. The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep.
Chang C; Tang X; Woodley DT; Chen M; Li W
Cells; 2023 Jan; 12(2):. PubMed ID: 36672211
[TBL] [Abstract][Full Text] [Related]
9. Proliferation, migration, and resistance to oxidative and thermal stresses of HT1080 cells with knocked out genes encoding Hsp90α and Hsp90β.
Petrenko V; Vrublevskaya V; Bystrova M; Masulis I; Kopylova E; Skarga Y; Zhmurina M; Morenkov O
Biochem Biophys Res Commun; 2023 Sep; 674():62-68. PubMed ID: 37406487
[TBL] [Abstract][Full Text] [Related]
10. Expressed as the sole Hsp90 of yeast, the alpha and beta isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90beta generates sensitivity to the Hsp90 inhibitor radicicol.
Millson SH; Truman AW; Rácz A; Hu B; Panaretou B; Nuttall J; Mollapour M; Söti C; Piper PW
FEBS J; 2007 Sep; 274(17):4453-63. PubMed ID: 17681020
[TBL] [Abstract][Full Text] [Related]
11. Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities.
Dernovšek J; Tomašič T
Pharmacol Ther; 2023 May; 245():108396. PubMed ID: 37001734
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous Responses and Isoform Compensation the Dim Therapeutic Window of Hsp90 ATP-Binding Inhibitors in Cancer.
Tang X; Chang C; Mosallaei D; Woodley DT; Schönthal AH; Chen M; Li W
Mol Cell Biol; 2022 Feb; 42(2):e0045921. PubMed ID: 34871064
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance.
Maiti S; Picard D
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139005
[TBL] [Abstract][Full Text] [Related]
14. Middle domain of human Hsp90 isoforms differentially binds Aha1 in human cells and alters Hsp90 activity in yeast.
Synoradzki K; Bieganowski P
Biochim Biophys Acta; 2015 Feb; 1853(2):445-52. PubMed ID: 25486457
[TBL] [Abstract][Full Text] [Related]
15. Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects.
Chan CT; Reeves RE; Geller R; Yaghoubi SS; Hoehne A; Solow-Cordero DE; Chiosis G; Massoud TF; Paulmurugan R; Gambhir SS
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2476-85. PubMed ID: 22895790
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the middle domains stabilizes Hsp90α dimer in a closed conformation with high affinity for p23.
Synoradzki K; Miszta P; Kazlauskas E; Mickevičiūtė A; Michailovienė V; Matulis D; Filipek S; Bieganowski P
Biol Chem; 2018 Mar; 399(4):337-345. PubMed ID: 29337688
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of heat shock protein 90 isoforms in small cell lung cancer.
Lee JH; Kang KW; Kim JE; Hwang SW; Park JH; Kim SH; Ji JH; Kim TG; Nam HY; Roh MS; Lee EH; Park MI; Kim MS; Lee HW
Int J Clin Exp Pathol; 2015; 8(8):9487-93. PubMed ID: 26464709
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System.
Zheng ZG; Zhang X; Liu XX; Jin XX; Dai L; Cheng HM; Jing D; Thu PM; Zhang M; Li H; Zhu J; Liu C; Xue B; Li Y; Chen L; Peng C; Zhu W; Wang L; Liu J; Li HJ; Li P; Xu X
Theranostics; 2019; 9(20):5769-5783. PubMed ID: 31534518
[No Abstract] [Full Text] [Related]
19. Chaperone Activity and Dimerization Properties of Hsp90
Morishima Y; Mehta RK; Yoshimura M; Lau M; Southworth DR; Lawrence TS; Pratt WB; Nyati MK; Osawa Y
Mol Pharmacol; 2018 Sep; 94(3):984-991. PubMed ID: 29941666
[TBL] [Abstract][Full Text] [Related]
20. ATP binding to Hsp90 is sufficient for effective chaperoning of p53 protein.
Walerych D; Gutkowska M; Klejman MP; Wawrzynow B; Tracz Z; Wiech M; Zylicz M; Zylicz A
J Biol Chem; 2010 Oct; 285(42):32020-8. PubMed ID: 20688913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
